WART REMOVER- salicylic acid plaster

Wart Remover by

Drug Labeling and Warnings

Wart Remover by is a Otc medication manufactured, distributed, or labeled by Pharmaplast SAE. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Facts

Active ingredient

Salicylic acid 40% in a plaster vehicle

Purpose

Wart remover adhesive pads

Indications:

• For the removal of common warts. The common wart is easily recognized by the rough 'cauliflower-like' appearance of the surface.
• For the removal of plantar warts on the bottom of the foot.
  The plantar wart is recognized by its location only on the bottom of the foot, its tenderness, and the interruption of the footprint pattern.

Warnings

• For external use only
• Do not use this product on irritated skin, on any area that is infected or reddened, if you are a diabetic, or if you have poor blood circulation.
• If discomfort persists, see your doctor.
• Do not use on moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face or mucous membranes.

• Keep out of reach of children.

Directions

For removal of Common and Plantar warts:

• Wash affected area.
• May soak wart in warm water for 5 minutes.
• Dry area thoroughly.
• Cut plaster to fit wart.
• Apply medicated plaster.
• Repeat procedure every 48 hours as needed (until wart is removed) for up to 12 weeks.

Inactive ingredient

Pressure sensitive adhesive fabric

SPL UNCLASSIFIED SECTION

CURE-AID®

Pharmaplast

Amria – Alexandria
Egypt
www.Pharmaplast-online.com

Packaging

INGREDIENTS AND APPEARANCE

WART REMOVER 
salicylic acid plaster

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 28691-0400
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	0.4 g

Inactive Ingredients
Ingredient Name	Strength
NATURAL LATEX RUBBER (UNII: 2LQ0UUW8IN)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
POLYISOBUTYLENE (75000 MW) (UNII: 596C33NS2J)
PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE) (UNII: 255PIF62MS)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 28691-0400-1	20 in 1 BOX; Type 4: Device Coated/Impregnated/Otherwise Combined with Drug	10/07/2016	08/22/2019
2	NDC: 28691-0400-2	10 in 1 BOX; Type 4: Device Coated/Impregnated/Otherwise Combined with Drug	08/22/2019

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part358B	10/07/2016

Labeler - Pharmaplast SAE (557735337)

Establishment
Name	Address	ID/FEI	Business Operations
Pharmaplast SAE		557735337	manufacture(28691-0400)